The growing consumer shift toward healthy drinks over alcoholic spirits, such aswineand beer, rising popularity of refreshment drinks, and growing innovations in non-alcoholic beverages are expected to propel the U.S. non-alcoholic beverages market growth. Beverage manufacturers in the country are inv...
We assessed the safety and efficacy of efruxifermin, a long-acting Fc-FGF21 fusion protein, for the treatment of NASH. BALANCED was a randomized, placebo-controlled study in patients with NASH conducted at 27 centers in the United States (ClinicalTrials.gov NCT03976401). Eighty patients, ...
Certified by the Centers for Disease Control and Prevention in health literacy, Matt leverages his experience in addiction research to provide hope to those struggling with substance use disorders. mgonzales@advancedrecoverysystems.com @bymattjgonzales editor , , Other Addiction Topics Alcohol ...
The FIB4 index was superior to other tested noninvasive markers of fibrosis in Japanese patients with NAFLD, with a high negative predictive value for excluding advanced fibrosis. The small number of cases of advanced fibrosis in this cohort meant that this study had limited power for validating ...
Although in NAFLD there is no specific treatment approved to treat liver injury, the diagnosis of advanced fibrosis could be very important to motivate the patient for diet or lifestyle modifications, for intensive treatment of complications of the metabolic syndrome or for weighing in favour of ant...
The latter serves as a mediator underlying how pro-inflammatory signals generated by hepatocytes in response to palmitate treatment act on macrophages to stimulate stimulator of interferon genes (STING) activation, thereby macrophage pro-inflammatory activation [54]. This adds new insights as to how ...